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Objective: To evaluate the variations in the detection of Porphyromonas
gingivalis and/or Aggregatibacter actinomycetemcomitans before and after systemic
administration of amoxicillin plus metronidazole in association with non-surgical
periodontal therapy (NSPT).
Background: The adjunctive use of antibiotics has been advocated to improve
the clinical outcomes of NSPT. However, no systematic review has investigated the
microbiological benefit of this combination.
Materials and Methods: An electronic search was conducted up to December
2015. Randomized clinical trials comparing the number of patients testing positive for
P. gingivalis and/or A. actinomycetemcomitans before and after NSPT with (test group)
or without (control group) amoxicillin plus metronidazole were included. The difference
between groups in the variation of positive patients was calculated using the inverse
variance method with a random effects model.
Results: The frequency of patients positive for A. actinomycetemcomitans was
decreased by 30% (p = 0.002) and by 25% (p= 0.01) in the test group compared to the
control group at 3- and 6-month follow-up, respectively. Similar findings were observed
when considering the frequency of patients positive for Porphyromonas gingivalis, with
a reduction by 28% (p < 0.0001), 32% (p < 0.0001), and 34% (p = 0.03) in the test
group compared to the control group at 3-, 6-, and 12-month follow-up, respectively.
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Conclusion: The systemic administration of amoxicillin plus metronidazole as an
adjunct to NSPT significantly decreased the number of patients positive for P. gingivalis
and A. actinomycetemcomitans compared with periodontal therapy alone or with a
placebo.
Keywords: Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, periodontitis/therapy,
amoxicillin, metronidazole, meta-analysis
INTRODUCTION
Periodontitis is associated with an accumulation of
microorganisms organized as a biofilm onto the dental
root surface. The microbial composition of the dental
biofilm includes a large number of oral bacteria, among
which only a limited number of periodontal pathogens
(Kolenbrander et al., 2010). Among these bacteria,
Porphyromonas gingivalis (P. gingivalis) and Aggregatibacter
actinomycetemcomitans (A. actinomycetemcomitans) are
considered to be major periodontal pathogens (American
Association of Periodontology, 1996)
Non-surgical periodontal therapy (NSPT) aims to reduce
the supra- and sub-gingival microbial load by the mechanical
disruption of the bacterial biofilm along the root surfaces
(Darveau, 2010). NSPT is defined as the mechanical plaque
removal, supra- and sub-gingival scaling, and root surface
debridement. It is carried out using various types of instruments,
such as hand instruments, sonic, and ultrasonic instruments.
It can be conducted alone or with the adjunctive use of
chemical antimicrobial agents. NSPT has been associated with
the reduction of the main periodontal pathogens, including
P. gingivalis and A. actinomycetemcomitans (Piconi et al., 2009).
Systemic administration of antibiotics has been advocated to
improve the microbiological effects of NSPT (van Winkelhoff
et al., 1996). In the last two decades, systematic reviews
with meta-analysis compared the clinical effects of several
combinations of antibiotics in complement to NSPT. A
recent systematic review with meta-analysis indicated that
the combination of amoxicillin (AMX) plus metronidazole
(MTZ) was associated with an improvement of clinical
periodontal variables, including probing pocket depth, and
clinical attachment gain (Keestra et al., 2015a,b), Moreover,
residual probing depth has been associated with the odds of
detecting P. gingivalis (Mombelli et al., 2000). High levels of
P. gingivalis and A. actinomycetemcomitans were also observed
in non-responding sites (Fujise et al., 2002).
On the other hand, antimicrobial resistance threatens the
effective prevention and treatment of an ever-increasing range
of infections caused by bacteria (Anonymous, 2015). The
administration of combined antibiotic therapy for Gram-
negative bacteria remains controversial, and may increase the
probability of resistance (van Winkelhoff et al., 2005; Feres et al.,
2015). Thus, the risk-benefit ratio of the use of systemic AMX
+ MTZ in addition to NSPT in chronic periodontitis may
be challenged. Indeed, the use of antibiotics does not belong
to the standard treatment guidelines of chronic periodontitis
(Herrera et al., 2002, 2008, 2012; Drisko, 2014). To date,
no meta-analysis has evaluated the microbiological benefits of
the combination of mechanical and antimicrobial therapies
on two major periodontal pathogens; i.e., P. gingivalis and
A. actinomycetemcomitans.
The aim of the present systematic review and meta-
analysis is to evaluate the detection of P. gingivalis and/or
A. actinomycetemcomitans after NSPT with or without systemic
administration of AMX+MTZ.
MATERIALS AND METHODS
Data Sources and Literature Search
A systematic review with meta-analysis was performed according
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) guidelines (Moher et al., 2015).
Relevant articles published in the English language were
identified up to December 2015, from MEDLINE, EMBASE, and
Cochrane Library databases. Gray literature was also explored
by searching non-published randomized controlled trials (RCTs)
in ICTRP (WHO), OpenSIGLE, and ClinicalTrials.gov registers.
Finally, electronic searches limited to abstracts were conducted
in the main dental and periodontal journals (i.e., Journal
of Dental Research, Journal of Periodontology, Annals of
Periodontology, Clinical Advances in Periodontics, Journal of
Clinical Periodontology, Journal of Periodontal Research, and
Oral Microbiology and Immunology). The search strategies
are detailed in Supplemental Table 1. The references listed of
articles of interest and in the main systematic reviews on
the topic were scrutinized to identify other relevant articles
(Supplemental Table 2).
Study Selection
The selection included RCTs with (i) patients receiving systemic
administration of AMX + MTZ as an adjunct to NSPT (test
group) vs. patients receiving either NSPT alone or with a
placebo (control group); (ii) microbiological technologies aiming
to identify P. gingivalis and/or A. actinomycetemcomitans from
subgingival plaque samples; (iii) a follow-up of at least 3
months; (iv) dichotomous data indicating the presence/absence
of P. gingivalis and A. actinomycetemcomitans.
Exclusion criteria were the following: (i) studies published in
non-English language, (ii) non-randomized trials, (iii) trials that
included surgical periodontal therapy.
Validity Assessment
Study selection was carried out independently by two blind
reviewers (CC and AD). The titles of articles retrieved from the
electronic search were screened. The abstracts of relevant articles
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were examined, and all studies that could be included were
retrieved. Discrepancies with regard to the inclusion or exclusion
of studies were resolved by discussion between the reviewers (CC
and AD). If a disagreement persisted, the judgment of a third
reviewer (PB) was considered decisive. The kappa coefficient used
to assess inter-rater reliability between the two reviewers was 0.91
for the global process of study selection (CI95%: 0.81–1.00).
Study Characteristics
The following data were extracted from each study in blinded
conditions by two independent investigators (AD and AB):
first author, year of publication, country, definition of cases,
sample size with loss of follow-up, mean age, sampling
strategy, microbiological technology, follow-up duration, type of
treatment, antibiotic regimens, maintenance regimen, and main
results.
The quality assessment of studies was evaluated in blinded
conditions by two independent investigators (AD and AB)
using the Cochrane Collaboration tool for assessment of the
risk of bias. This tool assesses seven main criteria (sequence
generation, allocation concealment, blinding of participants and
staff, blinding of outcome examiners, incomplete outcome data,
selective outcome reporting, and other sources of bias), all
recorded as adequate, unclear, or inadequate. We considered
studies were at low risk of bias if all criteria were met, and at high
risk of bias if not.
Data Analysis
In order to identify possible unpublished data in the selected
studies, the corresponding authors of the included articles were
contacted by email. Because the number of patients positive for a
bacterium could either increase or decrease during the follow-up
compared to baseline, the outcome was treated as a continuous
variable rather than a dichotomous variable. This variable was
defined as a “variation of positive patients.” A patient was positive
when the pathogen was detected. For test and control groups,
the difference in the number of positive patients from baseline
to follow-up examination was weighted. The following formula
was used: (a−b)/a, where a is the number of positive patients at
baseline and b is the number of positive patients at follow-up. The
“variation of positive patients” was then calculated in the test and
control groups.
The pooled difference for the “variation of positive patients”
between the test and control groups was calculated using
the inverse variance method. A random effects model was
selected to take into account heterogeneity due to the low
sample size of studies dealing with the topic. Subgroup analyses
were constructed according to the protocol of NSPT (full-
mouth disinfection vs. classical approach), sampling strategy
(deepest sites sampling vs. sampling of sites with various probing
depths), microbiological technology (low-sensitivity technologies
vs. high-sensitivity technologies), and type of periodontitis
(aggressive and chronic periodontitis). Only subgroups including
two studies or more were analyzed. The statistical significance
was set at p < 0.05, and 95% confidence interval (95%CI)
was calculated. The percentage of variability across studies
attributable to heterogeneity rather than chance was estimated
using the I2 statistic (Higgins et al., 2003). All analyses were
performed using R (R, version 3.2.3, R Development Core
Team (2008), R Foundation for Statistical Computing, Vienna,
Austria) and Review Manager (RevMan, version 5.2.8, The
Cochrane Collaboration (2012), The Nordic Cochrane Centre,
Copenhagen, Denmark).
RESULTS
Literature Search
After removal of the duplicate articles, 142 studies were identified
from the electronic search. Reading titles and abstracts reduced
the number to a total of 32 eligible studies. One eligible non-
published randomized clinical trial was identified in the gray
literature (ICTRP database, Trial ID: ISRCTN17605083). The
corresponding author was contacted but data were not obtained.
After reading of the full articles, 15 studies were excluded.
Reasons for exclusion are described in Supplemental Table 3.
Finally, 13 studies were included in the meta-analysis: data of
interest were found directly in seven studies (Winkel et al., 2001;
Rooney et al., 2002; Ehmke et al., 2005; Cionca et al., 2010;
Mestnik et al., 2010; Aimetti et al., 2012; Guerrero et al., 2014).
Unpublished data were obtained from the authors in six studies
(Xajigeorgiou et al., 2006; Matarazzo et al., 2008; Silva et al., 2011;
Silva-Senem et al., 2013; Miranda et al., 2014; Soares et al., 2014;
Figure 1).
Description of Included Studies
Supplemental Table 4 summarizes the characteristics of the
included studies. Five studies had a follow-up ≥12 month
(Berglundh et al., 1998; Ehmke et al., 2005; Silva-Senem et al.,
2013; Miranda et al., 2014; Soares et al., 2014). Full-mouth
disinfection therapy was performed within 48 h or less in four
studies (Ehmke et al., 2005; Cionca et al., 2010; Aimetti et al.,
2012; Guerrero et al., 2014). The antibiotic regimens lasted
between 7 and 14 days according to the different protocols used in
the studies. Bacterial culture was used in three studies (Berglundh
et al., 1998; Winkel et al., 2001; Rooney et al., 2002), PCR in eight
studies (Ehmke et al., 2005; Ribeiro Edel et al., 2009; Cionca et al.,
2010; Yek et al., 2010; Aimetti et al., 2012; Casarin et al., 2012;
Guerrero et al., 2014; Miranda et al., 2014), and checkerboard
DNA-DNA hybridization in six studies (Xajigeorgiou et al., 2006;
Matarazzo et al., 2008; Mestnik et al., 2010; Silva et al., 2011;
Silva-Senem et al., 2013; Soares et al., 2014).
The difference in the microbiological effect between groups
was not available in four studies (Berglundh et al., 1998; Rooney
et al., 2002; Matarazzo et al., 2008; Silva et al., 2011). In three
studies, a higher reduction of both bacteria was observed in the
test group compared with the control group (Cionca et al., 2010;
Mestnik et al., 2010; Soares et al., 2014). The mean reduction of
A. actinomycetemcomitans was founded to be higher in the test
group than in the control group in two studies (Ehmke et al.,
2005; Aimetti et al., 2012), and for P. gingivalis in two others
(Guerrero et al., 2014; Miranda et al., 2014). This reduction was
not significant between groups in six studies (Winkel et al., 2001;
Xajigeorgiou et al., 2006; Ribeiro Edel et al., 2009; Yek et al., 2010;
Casarin et al., 2012; Silva-Senem et al., 2013).
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FIGURE 1 | Flowchart of study inclusion process.
Quantitative Assessment
In the pooled data analysis, the percentages of subjects positive
for P. gingivalis at 3-, 6-, and 12-month follow-up in the test
group compared with the control group were decreased by 28%
(CI95%: 12–44), 32% (CI95%: 19–45), and 34% (CI95%: 4–64),
respectively (Figure 2).
For the analysis of the variation of A. actinomycetemcomitans,
one study was excluded from the meta-analysis because of a too
small sample size (Rooney et al., 2002). At 3-month follow-up,
the number of subjects positive for A. actinomycetemcomitans
was decreased by 30% (CI95%: 11–50) in the test group compared
with the control group. At 6-month follow-up, the number of
subjects positive for A. actinomycetemcomitans was decreased by
25% (CI95%: 6–45) in the test group compared with the control
group. At 12-month follow-up, no difference was observed
between groups (Figure 3).
Subgroup Analyses
Subgroup analyses (Tables 1, 2 for 3- and 6-month follow-up;
Supplemental Table 5 for 12-month follow-up) showed that the
type of NSPT, the sampling strategy, or the microbiological
technology did not influence the results for P. gingivalis at 3- and
6-month follow-up. The mean difference in the detection change
of A. actinomycetemcomitans between groups was not significant
when the classical NSPT was used (multiple session of NSPT),
whatever the follow-up. This lack of significant change was also
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FIGURE 2 | Percentage of change in the detection of P. gingivalis at 3, 6, and 12 months (antimicrobial therapy in complement to NSPT (test) vs. NSPT
alone or with placebo control).
found when biofilm collection was done in sites with various
probing depths at 6- and 12-month follow-up. The subgroup
analyses dealing with the type of periodontitis indicated a
significant difference between groups for both pathogens in
chronic periodontitis. In contrast, no difference was found in
aggressive periodontitis for both bacteria, expect for P. gingivalis
at 6-month follow-up.
Only five studies met all criteria for low risk of bias (Mestnik
et al., 2010; Aimetti et al., 2012; Casarin et al., 2012; Guerrero
et al., 2014; Miranda et al., 2014; Supplemental Figure 1). When
limiting the analyses to those studies, results were unchanged,
except for the mean difference in the detection change of
A. actinomycetemcomitans at 6-month follow-up, which was not
significant (for P. gingivalis/A. actinomycetemcomitans at 3- and
6-month follow-up, respectively 17% (CI95%: 4–30)/24% (CI95%:
0–48) and 42% (CI95%: 21–62)/33% (CI95%:−4–69)).
DISCUSSION
The results of the present meta-analyses show that at 6-month
follow-up the number of positive subjects for P. gingivalis is
reduced by 32% (p < 0.001) in the test group treated by
NSPT in adjunction of systemic antibiotics compared to control.
At 6-month follow-up, the number of positive subjects for
A. actinomycetemcomitans was reduced by 25% (p = 0.01) in
the test group compared to control. At 12-month follow-up,
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FIGURE 3 | Percentage of change in the detection of A. actinomycetemcomitans at 3, 6, and 12 months (antimicrobial therapy in complement to NSPT
(test) vs. NSPT alone or with placebo control).
a significant reduction between groups was still observed for
P. gingivalis; whereas, this difference was not significant for
A. actinomycetemcomitans. This lack of significance could be
related to the few data available at more than 6-month of follow-
up, and, as a consequence, it should be interpreted with caution.
In the same vein, few studies are available for the performed
subgroup analyses; particularly, the analyses limited to the studies
assessed at low risk of bias resulted in questionable results. For
instance, it failed to show a significant difference between groups
for the detection of A. actinomycetemcomitans when classical
NSPT was used (multiple session of NSPT). When a full-mouth
disinfection protocol was implemented, this difference was
significant (p < 0.01) (Table 1). This result may strengthen the
fact that NSPT must be carried out in the shortest possible time
span in case of patients positive for A. actinomycetemcomitans
and for who antibiotic therapy is planned (Herrera et al., 2012).
Similarly, whereas a significant difference was observed between
groups when antibiotics were taken for 7 days, no significant
difference was observed for a longer duration. Included studies in
which antibiotics were taken for 7 days were all conducted with
a full-mouth disinfection protocol, whereas multiple session of
NSPT were used in studies with longer antimicrobial treatments.
Despite the beneficial effect of adjunctive antimicrobial regimen
compared with control, this outcome indicates that mechanical
debridement is the cornerstone of periodontal therapy.
Interestingly, the adjunction of AMX + MTZ to NSPT
does not bring advantages regarding A. actinomycetemcomitans
in aggressive periodontitis. Several studies have demonstrated
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TABLE 1 | Impact of mechanical treatment protocol, sampling methods, microbiological technology, type of periodontitis and duration of antibiotic
regimen on the percentage of change in the detection of A. actinomycetemcomitans at 3-, 6-, and 12-month follow-up.
Mean difference (95% CI) I2(%)
AT 3-MONTH FOLLOW-UP
Full-mouth disinfection (1,2,3,8,10) 0.33 (0.04–0.63)* 80
Multiple session of NSPT (5,6,7,9) 0.30 (−0.02–0.62) 72
Biofilm collection, deep sites only (PD ≥ 6 mm) or deepest sites (2,3,10) 0.48 (0.23–0.73)§ 0
Biofilm collection, sites with different probing depths (1,5,6,7,8,9) 0.22 (0.02–0.43)* 78
Microbiological technology, Non-enzymatic technique (1,2,3,5,6,7,8,9) 0.27 (0.08–0.47)§ 78
Aggressive periodontitis (1,6,8) 0.12 (−0.09–0.34) 66
Chronic periodontitis (2,3,5,7,9,10) 0.42 (0.16–0.69)§ 63
Antibiotic regimen for 7 days (1,2,10) 0.46 (0.23–0.70)§ 0
Antibiotic regimen for 14 days (5,6,7,9) 0.30 (−0.02–0.62) 72
AT 6-MONTH FOLLOW-UP
Full-mouth disinfection (1,2,3,4,8,11) 0.32 (0.07–0.57)§ 87
Multiple session of NSPT (6,9) −0.05 (−0.10–0.00) 0
Biofilm collection, deep sites only (PD ≥ 6 mm) or deepest sites (2,3,4,11) 0.34 (0.07–0.61)* 63
Biofilm collection, sites with different probing depths (1,6,8,9) 0.18 (−0.13–0.49) 83
Microbiological technology, Non-enzymatic technique (1,2,3,4,6,8,9,11) 0.25 (0.06–0.45)* 63
Aggressive periodontitis (1,4,6,8,11) 0.18 (−0.03–0.39) 80
Chronic periodontitis (2,3,9) 0.39 (0.05–0.73)* 57
Antibiotic regimen for 7 days (1,2,4,11) 0.35 (0.06–0.64)* 69
Antibiotic regimen for 14 days (6,9) 0.05 (−0.21–0.32) 0
Inverse variance method, random effects model. *p < 0.05; §p < 0.01. Full-mouth disinfection/multiple sessions: all non-surgical periodontal therapy (NSPT) realized within 48 h or
less/in more than 48 h. PD, Probing depth. 1, Aimetti et al. (2012); 2, Cionca et al. (2010); 3, Ehmke et al. (2005); 4, Guerrero et al. (2014); 5, Matarazzo et al. (2008); 6, Mestnik et al.
(2010); 7, Silva et al. (2011); 8, Silva-Senem et al. (2013); 9, Soares et al. (2014); 10, Winkel et al. (2001); 11, Xajigeorgiou et al. (2006).
that the detection and quantity of A. actinomycetemcomitans is
higher in patients with this type of periodontitis (Könönen and
Müller, 2014). Thus, on a biological point of view, our results
showing a lack of statistically significant difference between
the test and control groups in aggressive periodontitis might
be explained by the difficulty in reaching a level of non-
detection for A. actinomycetemcomitans in this specific type
of patients, even when antibiotics are used. Moreover, on a
methodological point of view, the dichotomic approach using
the patient as the statistical unit may also contribute to explain
the absence of significant difference between groups. Indeed, it
is possible that the mean quantity of A. actinomycetemcomitans
was significantly reduced after treatment but remains above the
detection threshold also in the test group (Table 1).
Six studies included in the quantitative analyses, and sharing
similar clinical data, allowed to further explore the relationship
between improved clinical parameters (in full-mouth, moderate
and severe pockets) and variations in the number of positive
subjects for both bacteria (Winkel et al., 2001; Matarazzo et al.,
2008; Mestnik et al., 2010; Silva et al., 2011; Aimetti et al., 2012;
Miranda et al., 2014). Distributions of microbial and clinical
parameters shared similar patterns, with better clinical results
related to higher reduction in the number of positive subjects
(data not shown).
The present systematic review and meta-analysis has several
strengths. To our knowledge, this is the first meta-analysis to
provide a quantitative evaluation of the microbiological effects
of systemic administration of AMX + MTZ in adjunction to
the standard NSPT. The major novelty of the present study is
to compare the presence/absence of bacteria according to the
detection threshold, instead of mean counts. The reduction of the
mean count of bacteria is less clinically meaningful than the rate
of non-detection. The non-detection approach guaranties levels
compatible with periodontal health independently of baseline
values. Also, a strict study selection was performed. Studies with
less than 3-month follow-up were excluded because previous
observations have found that most clinical and microbiological
improvements were observed 3 months after NSPT and
antimicrobial therapy (Badersten et al., 1984; Berglundh et al.,
1998;Winkel et al., 2001; Haffajee et al., 2006; Cionca et al., 2010).
Moreover, unpublished data were collected and gray literature
was explored. Therefore, the sample size of the meta-analysis
resulted relatively large (536 subjects at baseline; 13 RCTs). In
addition, the 12-month follow-up strengthened the outcomes of
RCTs, showing a tendency of bacterial recolonization over time.
However, the present study has also some limitations.
Moderate to high heterogeneity was found, probably due
to the differences between the included studies. The use of
different microbiological technologies may also be challenged.
Unfortunately, thresholds of detection were not indicated
in all studies. Thus, the subgroup analysis with specific
detection thresholds was not possible. Therefore, it could be
raised that the outcomes are influenced by the sensitivity
of microbiological technologies presenting different levels of
detection. In the literature, it has been shown better detection
properties for PCR and DNA-DNA hybridization compared with
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TABLE 2 | Impact of mechanical treatment protocol, sampling methods, microbiological technology, type of periodontitis, and duration of antibiotic
regimen on the percentage of change in the detection of P. gingivalis at 3- and 6-month follow-up.
Mean difference (95% CI) I2(%)
AT 3-MONTH FOLLOW-UP
Full-mouth disinfection (1,2,3,10,12) 0.41 (0.12–0.70)§ 76
Multiple session of NSPT (5,6,7,8,9,11) 0.17 (0.00–0.33) 62
Biofilm collection, deep sites only (PD ≥ 6 mm) or deepest sites (2,3,8,12) 0.60 (0.35–0.85)§ 39
Biofilm collection, sites with different probing depths (1,5,6,7,9,10,11) 0.13 (0.01–0.26)* 51
Microbiological technology, Non-enzymatic technique (1,2,3,5,6,7,9,10,11) 0.23 (0.07–0.39)§ 73
Microbiological technology, Enzymatic technique (8,12) 0.60 (0.31–0.88)§ 0
Chronic periodontitis (2,3,5,7,8) 0.32 (0.00–0.65)* 85
Aggressive periodontitis (1,6,10) 0.14 (−0.02–0.30) 0
Antibiotic regimen for 7 days (1,2,8,12) 0.38 (0.14–0.62)§ 40
Antibiotic regimen for 14 days (5,6,9,11) 0.15 (−0.08–0.38) 74
AT 6-MONTH FOLLOW-UP
Full-mouth disinfection (1,2,3,4,10,13) 0.32 (0.13–0.50)§ 54
Multiple session of NSPT (6,8,11) 0.37 (0.20–0.54)§ 0
Biofilm collection, deep sites only (PD ≥ 6 mm) or deepest sites (2,3,4,8,13) 0.35 (0.12–0.58)§ 37
Biofilm collection, sites with different probing depths (1,6,10,11) 0.30 (0.14–0.46)§ 45
Microbiological technology, Non-enzymatic technique (1,2,3,4,6,10,11,13) 0.32 (0.19–0.46)§ 43
Aggressive periodontitis (1,4,6,10,13) 0.25 (0.10–0.40)§ 26
Chronic periodontitis (2,3,8,11) 0.41 (0.22–0.60)§ 20
Antibiotic regimen for 7 days (1,2,4,8,13) 0.30 (0.14–0.46)§ 0
Antibiotic regimen for 14 days (6,11) 0.38 (0.20–0.55)§ %
Inverse variance method, random effects model. *p < 0.05; §p < 0.01. Full-mouth disinfection/multiple sessions: all non-surgical periodontal therapy (NSPT) realized within 48 h or
less/in more than 48 h. PD, Probing depth. 1, Aimetti et al. (2012); 2, Cionca et al. (2010); 3, Ehmke et al. (2005); 4, Guerrero et al. (2014); 5, Matarazzo et al. (2008); 6, Mestnik et al.
(2010); 7, Miranda et al. (2014); 8, Rooney et al. (2002); 9, Silva et al. (2011); 10, Silva-Senem et al. (2013); 11, Soares et al. (2014); 12, Winkel et al. (2001); 13, Xajigeorgiou et al.
(2006).
cultures and enzymatic techniques. Nevertheless, comparative
studies have demonstrated a good to excellent agreement
between quantitative PCR and culture when P. gingivalis and
A. actinomycetemcomitans were investigated (Lau et al., 2004;
Jervoe-Storm et al., 2005). In the same vein, when comparing
PCR with checkerboard DNA hybridization, the agreement
between the two technologies was good for P. gingivalis and
A. Actinomycetemcomitans detection (Haffajee et al., 2009).
Finally, detection thresholds may differ between two studies
using the same microbiological technology. Therefore, we
also conducted subgroup analyses based on microbiological
technologies. High-detection technologies (PCR and DNA-DNA
hybridization) were compared with low-detection technologies
(cultures and enzymatic methods). These analyses did not
change the main outcome (Tables 1, 2). It may also be
assumed that patient’s compliance may impact the results.
Unfortunately, it was not possible to evaluate the influence of the
periodontal maintenance regimen on bacterial recolonization,
because maintenance programs were unclear in 8 out of
the 13 included studies. Moreover, age and gender may also
influence the results. In all studies included in the quantitative
assessment, excepted one (Rooney et al., 2002), age, and gender
did not differ between groups at baseline. When this latter
study was removed, the conclusions were unchanged. The
percentages of subjects positive for P. gingivalis at 3- and 6-
month follow-up in the test group compared with the control
group were decreased respectively by 27% (CI95%: 10–43) and
32% (CI95%: 19–46) (all p < 0.01). Finally, only P. gingivalis and
A. actinomycetemcomitanswere considered in this meta-analysis.
Recent data indicate that P. gingivalis may serve as surrogate
markers of the bacterial community dysbiosis (Hajishengallis
et al., 2012). In addition, P. gingivalis is implicated, via
gingipains, in the association between periodontal diseases and
systemic disorders (Olsen and Potempa, 2014; Alfakry et al.,
2016). A. actinomycetemcomitans has long been associated with
aggressive periodontitis (Könönen and Müller, 2014; Herbert
et al., 2016). In addition, A. actinomycetemcomitans may play
a role in the polymicrobial synergy that initiate the disease
(Nibali, 2015). Consequently, these bacteria may be view as major
microbiological risk factors. This is the reason why there are
numerous RCTs investigating these bacteria.
The systemic administration of amoxicillin plus
metronidazole as an adjunct to NSPT significantly, but modestly,
decreased the number of patients positive for P. gingivalis and
A. actinomycetemcomitans compared with periodontal therapy
alone or with a placebo.
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